Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Plasma Cell × spartalizumab × Clear all

Sponsor

Conditions

Melanoma 7 Pancreatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Head and Neck Neoplasms 3 Sarcoma 2 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Liver Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Kidney Neoplasms 1 Kidney Diseases 1

Interventions

Cyclophosphamide 28 Dexamethasone 27 Melphalan 21 Busulfan 21 fludarabine phosphate 20 Bortezomib 19 Lenalidomide 18 Tacrolimus 17 Whole-Body Irradiation 15 Peripheral Blood Stem Cell Transplantation 14 Mycophenolic Acid 14 Antilymphocyte Serum 14 fludarabine 12 Calcium Dobesilate 12 Thalidomide 10 Filgrastim 10 Granulocyte Colony-Stimulating Factor 9 Methotrexate 8 pomalidomide 6 Radiotherapy 6 Cyclosporine 6 Stem Cell Transplantation 5 Rituximab 5 Etoposide 5 Cord Blood Stem Cell Transplantation 5 carfilzomib 4 Surveys and Questionnaires 4 Sirolimus 4 Methylprednisolone 4 Hematopoietic Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡